| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 32 | 2025 | 79 | 6.090 |
Why?
|
| Docosahexaenoic Acids | 18 | 2022 | 105 | 4.150 |
Why?
|
| Lung | 28 | 2025 | 379 | 4.010 |
Why?
|
| Inflammation | 19 | 2022 | 636 | 3.910 |
Why?
|
| Bronchopulmonary Dysplasia | 14 | 2025 | 47 | 3.350 |
Why?
|
| Prenatal Exposure Delayed Effects | 7 | 2019 | 110 | 2.490 |
Why?
|
| Premature Birth | 7 | 2022 | 57 | 2.300 |
Why?
|
| MicroRNAs | 9 | 2020 | 301 | 2.290 |
Why?
|
| Dietary Supplements | 17 | 2022 | 254 | 2.080 |
Why?
|
| Mice | 47 | 2025 | 4654 | 1.670 |
Why?
|
| Animals, Newborn | 21 | 2025 | 180 | 1.650 |
Why?
|
| Pregnancy | 21 | 2020 | 1191 | 1.530 |
Why?
|
| Lung Injury | 7 | 2018 | 32 | 1.490 |
Why?
|
| Animals | 56 | 2025 | 10423 | 1.480 |
Why?
|
| Mice, Inbred C3H | 21 | 2025 | 74 | 1.470 |
Why?
|
| Microfilament Proteins | 4 | 2018 | 31 | 1.380 |
Why?
|
| Cell Adhesion Molecules | 4 | 2018 | 69 | 1.350 |
Why?
|
| Autism Spectrum Disorder | 5 | 2022 | 24 | 1.340 |
Why?
|
| Phosphoproteins | 4 | 2018 | 120 | 1.340 |
Why?
|
| Profilins | 3 | 2018 | 4 | 1.290 |
Why?
|
| Cofilin 1 | 3 | 2018 | 4 | 1.290 |
Why?
|
| Infant, Newborn | 23 | 2022 | 885 | 1.290 |
Why?
|
| Glutathione Reductase | 12 | 2020 | 22 | 1.280 |
Why?
|
| Milk, Human | 4 | 2022 | 86 | 1.250 |
Why?
|
| Infant, Extremely Premature | 3 | 2020 | 12 | 1.240 |
Why?
|
| Fetal Development | 5 | 2019 | 25 | 1.210 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2022 | 39 | 1.190 |
Why?
|
| Diet, High-Fat | 3 | 2019 | 137 | 1.180 |
Why?
|
| Infant, Premature | 10 | 2022 | 141 | 1.150 |
Why?
|
| Female | 47 | 2025 | 15156 | 1.140 |
Why?
|
| Cyclooxygenase 2 | 5 | 2022 | 68 | 1.130 |
Why?
|
| Fatty Acids, Omega-6 | 3 | 2022 | 22 | 1.030 |
Why?
|
| Liver | 11 | 2024 | 440 | 1.000 |
Why?
|
| Pregnancy Complications | 3 | 2017 | 111 | 0.990 |
Why?
|
| Brain | 3 | 2016 | 741 | 0.990 |
Why?
|
| Pulmonary Alveoli | 9 | 2018 | 33 | 0.980 |
Why?
|
| Fetal Growth Retardation | 3 | 2014 | 32 | 0.900 |
Why?
|
| Lipopolysaccharides | 10 | 2024 | 157 | 0.860 |
Why?
|
| Disease Models, Animal | 15 | 2022 | 1461 | 0.840 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 12 | 0.830 |
Why?
|
| Biological Specimen Banks | 2 | 2020 | 10 | 0.820 |
Why?
|
| Male | 33 | 2024 | 13491 | 0.770 |
Why?
|
| Gestational Age | 7 | 2021 | 146 | 0.770 |
Why?
|
| Obesity | 2 | 2019 | 669 | 0.760 |
Why?
|
| Lactation | 4 | 2022 | 61 | 0.740 |
Why?
|
| Gene Expression | 4 | 2022 | 417 | 0.740 |
Why?
|
| Maternal Exposure | 3 | 2018 | 19 | 0.740 |
Why?
|
| Apoptosis | 5 | 2022 | 775 | 0.730 |
Why?
|
| Infant | 15 | 2022 | 1004 | 0.730 |
Why?
|
| Humans | 48 | 2022 | 28097 | 0.720 |
Why?
|
| DNA Methylation | 3 | 2020 | 152 | 0.710 |
Why?
|
| Thioredoxin Reductase 1 | 4 | 2019 | 13 | 0.710 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2013 | 131 | 0.700 |
Why?
|
| Glutathione | 12 | 2020 | 76 | 0.680 |
Why?
|
| Child Development | 3 | 2021 | 78 | 0.680 |
Why?
|
| Arginase | 2 | 2018 | 6 | 0.640 |
Why?
|
| Breast Feeding | 2 | 2019 | 94 | 0.630 |
Why?
|
| Jagged-1 Protein | 2 | 2016 | 6 | 0.630 |
Why?
|
| Heparin | 1 | 2019 | 111 | 0.630 |
Why?
|
| Arginine | 3 | 2014 | 42 | 0.620 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2016 | 123 | 0.620 |
Why?
|
| Cell Movement | 4 | 2018 | 373 | 0.610 |
Why?
|
| Microglia | 2 | 2016 | 64 | 0.600 |
Why?
|
| Lung Diseases | 3 | 2015 | 43 | 0.600 |
Why?
|
| Xenobiotics | 1 | 2018 | 5 | 0.590 |
Why?
|
| Actins | 2 | 2018 | 96 | 0.590 |
Why?
|
| Biomarkers | 9 | 2022 | 765 | 0.580 |
Why?
|
| Cardiovascular System | 1 | 2018 | 40 | 0.580 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 35 | 0.570 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 33 | 0.550 |
Why?
|
| Epithelial Cells | 3 | 2019 | 248 | 0.550 |
Why?
|
| Milk Banks | 1 | 2017 | 1 | 0.550 |
Why?
|
| Pasteurization | 1 | 2017 | 2 | 0.550 |
Why?
|
| Nanostructures | 1 | 2018 | 64 | 0.550 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 28 | 0.550 |
Why?
|
| Nutritive Value | 1 | 2017 | 6 | 0.550 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2016 | 1 | 0.530 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2019 | 67 | 0.530 |
Why?
|
| Hepcidins | 1 | 2016 | 2 | 0.530 |
Why?
|
| Gelsolin | 1 | 2016 | 3 | 0.520 |
Why?
|
| Myelin Sheath | 1 | 2016 | 27 | 0.520 |
Why?
|
| Oxygen | 10 | 2025 | 233 | 0.510 |
Why?
|
| Vimentin | 1 | 2016 | 28 | 0.510 |
Why?
|
| Pneumonia | 2 | 2022 | 89 | 0.510 |
Why?
|
| Prostaglandins | 3 | 2012 | 13 | 0.510 |
Why?
|
| Macrophages | 3 | 2016 | 295 | 0.500 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 27 | 0.500 |
Why?
|
| Phosphorylation | 6 | 2018 | 578 | 0.500 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2021 | 179 | 0.490 |
Why?
|
| Glutathione Disulfide | 3 | 2012 | 14 | 0.480 |
Why?
|
| Lung Neoplasms | 2 | 2016 | 356 | 0.480 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 1576 | 0.480 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 3 | 2018 | 64 | 0.470 |
Why?
|
| Receptors, Notch | 1 | 2015 | 45 | 0.470 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 148 | 0.460 |
Why?
|
| Thioredoxins | 3 | 2010 | 26 | 0.460 |
Why?
|
| Oxidative Stress | 5 | 2025 | 668 | 0.440 |
Why?
|
| Solid Phase Extraction | 1 | 2013 | 2 | 0.440 |
Why?
|
| Body Weight | 7 | 2016 | 250 | 0.430 |
Why?
|
| Glycation End Products, Advanced | 1 | 2013 | 17 | 0.430 |
Why?
|
| Neutrophil Infiltration | 2 | 2010 | 19 | 0.430 |
Why?
|
| Oligodendroglia | 1 | 2013 | 15 | 0.430 |
Why?
|
| RNA, Messenger | 8 | 2019 | 659 | 0.430 |
Why?
|
| Contraceptive Agents, Female | 3 | 2019 | 9 | 0.400 |
Why?
|
| Central Nervous System | 1 | 2012 | 38 | 0.400 |
Why?
|
| Coenzyme A | 4 | 2010 | 13 | 0.390 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 17 | 0.380 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 64 | 0.360 |
Why?
|
| Child, Preschool | 8 | 2022 | 1146 | 0.360 |
Why?
|
| Gene Expression Regulation | 5 | 2018 | 632 | 0.360 |
Why?
|
| Cytokines | 3 | 2019 | 447 | 0.350 |
Why?
|
| Prospective Studies | 5 | 2019 | 1248 | 0.350 |
Why?
|
| Aurothioglucose | 5 | 2019 | 11 | 0.350 |
Why?
|
| Carrier Proteins | 2 | 2010 | 252 | 0.350 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2018 | 122 | 0.340 |
Why?
|
| Fibrosis | 4 | 2016 | 133 | 0.340 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 16 | 0.330 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 128 | 0.320 |
Why?
|
| Cells, Cultured | 4 | 2018 | 985 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 3 | 2016 | 34 | 0.320 |
Why?
|
| Diquat | 2 | 2006 | 3 | 0.320 |
Why?
|
| Herbicides | 2 | 2006 | 5 | 0.310 |
Why?
|
| Cell Nucleus | 2 | 2016 | 138 | 0.310 |
Why?
|
| Proteins | 2 | 2013 | 252 | 0.310 |
Why?
|
| Retina | 1 | 2012 | 436 | 0.310 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2019 | 21 | 0.280 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 366 | 0.270 |
Why?
|
| Placenta | 3 | 2018 | 78 | 0.270 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2006 | 15 | 0.260 |
Why?
|
| Sulfhydryl Compounds | 1 | 2006 | 30 | 0.260 |
Why?
|
| Interleukin-6 | 2 | 2020 | 193 | 0.260 |
Why?
|
| Young Adult | 6 | 2019 | 2733 | 0.260 |
Why?
|
| Adult | 7 | 2019 | 7740 | 0.260 |
Why?
|
| Child | 7 | 2022 | 2242 | 0.260 |
Why?
|
| Kidney Diseases | 1 | 2006 | 61 | 0.250 |
Why?
|
| Glutathione Peroxidase | 3 | 2019 | 26 | 0.250 |
Why?
|
| Double-Blind Method | 3 | 2022 | 417 | 0.250 |
Why?
|
| HMGB1 Protein | 2 | 2016 | 5 | 0.250 |
Why?
|
| Thioredoxin-Disulfide Reductase | 3 | 2016 | 14 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 3 | 2016 | 343 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 607 | 0.240 |
Why?
|
| Selenium | 1 | 2025 | 17 | 0.230 |
Why?
|
| Bile Acids and Salts | 1 | 2024 | 23 | 0.230 |
Why?
|
| Diet | 2 | 2018 | 232 | 0.220 |
Why?
|
| Oxidation-Reduction | 3 | 2012 | 365 | 0.220 |
Why?
|
| Myocardium | 2 | 2017 | 192 | 0.210 |
Why?
|
| Smad2 Protein | 2 | 2014 | 17 | 0.210 |
Why?
|
| Disulfides | 1 | 2003 | 34 | 0.200 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 3 | 2018 | 40 | 0.200 |
Why?
|
| Cell Nucleolus | 1 | 2002 | 26 | 0.200 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 33 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2024 | 123 | 0.200 |
Why?
|
| Autistic Disorder | 1 | 2022 | 11 | 0.190 |
Why?
|
| Cell Count | 2 | 2013 | 86 | 0.190 |
Why?
|
| Cohort Studies | 3 | 2019 | 887 | 0.190 |
Why?
|
| Heart Ventricles | 2 | 2014 | 137 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2022 | 35 | 0.190 |
Why?
|
| Neutrophils | 3 | 2012 | 181 | 0.190 |
Why?
|
| Signal Transduction | 3 | 2022 | 1435 | 0.180 |
Why?
|
| Caspase 3 | 3 | 2022 | 58 | 0.180 |
Why?
|
| gamma-Linolenic Acid | 2 | 2018 | 2 | 0.180 |
Why?
|
| Risk Factors | 4 | 2021 | 2081 | 0.180 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2018 | 8 | 0.180 |
Why?
|
| Mice, Knockout | 5 | 2022 | 848 | 0.180 |
Why?
|
| Chemokine CCL2 | 3 | 2022 | 47 | 0.170 |
Why?
|
| Amniotic Fluid | 1 | 2020 | 6 | 0.170 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2020 | 6 | 0.170 |
Why?
|
| Chorioamnionitis | 1 | 2020 | 4 | 0.170 |
Why?
|
| Myocardial Contraction | 2 | 2017 | 62 | 0.170 |
Why?
|
| Haptoglobins | 1 | 2020 | 22 | 0.170 |
Why?
|
| Histones | 1 | 2020 | 95 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2018 | 806 | 0.170 |
Why?
|
| Parturition | 1 | 2020 | 17 | 0.170 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 413 | 0.170 |
Why?
|
| Fetal Blood | 1 | 2020 | 39 | 0.170 |
Why?
|
| Risk | 1 | 2020 | 137 | 0.160 |
Why?
|
| Heparin Lyase | 1 | 2019 | 3 | 0.160 |
Why?
|
| Polysaccharide-Lyases | 1 | 2019 | 3 | 0.160 |
Why?
|
| Flavobacterium | 1 | 2019 | 3 | 0.160 |
Why?
|
| Tyrosine | 2 | 2010 | 92 | 0.160 |
Why?
|
| Arachidonate 5-Lipoxygenase | 2 | 2010 | 12 | 0.160 |
Why?
|
| Weaning | 1 | 2019 | 18 | 0.160 |
Why?
|
| Progestins | 1 | 2019 | 11 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2018 | 206 | 0.160 |
Why?
|
| Arachidonic Acids | 1 | 2019 | 4 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 269 | 0.150 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 29 | 0.150 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 32 | 0.150 |
Why?
|
| Placenta Accreta | 1 | 2018 | 8 | 0.150 |
Why?
|
| Trophoblasts | 1 | 2018 | 14 | 0.150 |
Why?
|
| Rats, Inbred F344 | 5 | 2006 | 174 | 0.150 |
Why?
|
| Random Allocation | 1 | 2018 | 151 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 33 | 0.150 |
Why?
|
| Cognition | 2 | 2018 | 324 | 0.150 |
Why?
|
| Treatment Outcome | 3 | 2019 | 2379 | 0.150 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 11 | 0.150 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 1319 | 0.150 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 1 | 2018 | 3 | 0.150 |
Why?
|
| Ethylene Glycol | 1 | 2018 | 1 | 0.150 |
Why?
|
| Ethylene Glycols | 1 | 2018 | 2 | 0.150 |
Why?
|
| Laxatives | 1 | 2018 | 4 | 0.150 |
Why?
|
| Ornithine Decarboxylase | 1 | 2018 | 9 | 0.150 |
Why?
|
| Nutrition Policy | 1 | 2018 | 23 | 0.150 |
Why?
|
| Enzyme Induction | 1 | 2018 | 28 | 0.150 |
Why?
|
| Calcium-Binding Proteins | 2 | 2015 | 62 | 0.150 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2019 | 63 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 463 | 0.140 |
Why?
|
| Desmin | 1 | 2017 | 2 | 0.140 |
Why?
|
| Connexin 43 | 1 | 2017 | 4 | 0.140 |
Why?
|
| Ventricular Pressure | 1 | 2017 | 6 | 0.140 |
Why?
|
| Language Development | 1 | 2017 | 5 | 0.140 |
Why?
|
| Sensation | 1 | 2017 | 12 | 0.140 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 24 | 0.140 |
Why?
|
| Kidney | 2 | 2012 | 286 | 0.140 |
Why?
|
| Organ Size | 3 | 2012 | 87 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2018 | 78 | 0.140 |
Why?
|
| Bacterial Infections | 2 | 2019 | 56 | 0.140 |
Why?
|
| Milk Proteins | 1 | 2017 | 19 | 0.140 |
Why?
|
| North America | 1 | 2017 | 40 | 0.140 |
Why?
|
| HIV Infections | 1 | 2019 | 159 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 101 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 112 | 0.130 |
Why?
|
| Antioxidants | 1 | 2019 | 223 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2017 | 41 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 74 | 0.130 |
Why?
|
| Dehydroepiandrosterone | 1 | 2016 | 15 | 0.130 |
Why?
|
| Encephalitis | 1 | 2016 | 18 | 0.130 |
Why?
|
| Amino Acids | 1 | 2017 | 84 | 0.130 |
Why?
|
| Cell Line | 3 | 2016 | 696 | 0.130 |
Why?
|
| A549 Cells | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cyclic AMP | 1 | 2016 | 87 | 0.130 |
Why?
|
| Amidohydrolases | 1 | 2016 | 12 | 0.130 |
Why?
|
| Sex Factors | 1 | 2017 | 466 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2016 | 55 | 0.130 |
Why?
|
| Protein Transport | 1 | 2016 | 158 | 0.130 |
Why?
|
| Heart Rate | 1 | 2017 | 379 | 0.120 |
Why?
|
| Behavior, Animal | 1 | 2016 | 108 | 0.120 |
Why?
|
| Autopsy | 1 | 2015 | 25 | 0.120 |
Why?
|
| Bone Density | 1 | 2016 | 100 | 0.120 |
Why?
|
| DNA Modification Methylases | 1 | 2015 | 13 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 162 | 0.120 |
Why?
|
| Presenilin-2 | 1 | 2015 | 2 | 0.120 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2015 | 3 | 0.120 |
Why?
|
| Presenilin-1 | 1 | 2015 | 4 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2016 | 58 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2016 | 172 | 0.120 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 35 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2014 | 514 | 0.120 |
Why?
|
| Rats | 5 | 2006 | 1576 | 0.120 |
Why?
|
| Iron | 1 | 2016 | 116 | 0.120 |
Why?
|
| Time Factors | 2 | 2010 | 1592 | 0.120 |
Why?
|
| Phagocytosis | 2 | 2013 | 80 | 0.120 |
Why?
|
| Serine | 1 | 2014 | 51 | 0.120 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2006 | 168 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 66 | 0.120 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 165 | 0.110 |
Why?
|
| Protein Binding | 1 | 2016 | 658 | 0.110 |
Why?
|
| Necrosis | 2 | 2006 | 85 | 0.110 |
Why?
|
| Sarcomeres | 1 | 2014 | 2 | 0.110 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 7 | 0.110 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2014 | 4 | 0.110 |
Why?
|
| Smad3 Protein | 1 | 2014 | 10 | 0.110 |
Why?
|
| S100 Proteins | 1 | 2013 | 6 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 40 | 0.110 |
Why?
|
| Calibration | 1 | 2013 | 29 | 0.110 |
Why?
|
| Secretoglobins | 1 | 2013 | 2 | 0.110 |
Why?
|
| Uteroglobin | 1 | 2013 | 5 | 0.110 |
Why?
|
| Annexin A1 | 1 | 2013 | 3 | 0.110 |
Why?
|
| Riboflavin | 2 | 2010 | 6 | 0.110 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2014 | 54 | 0.110 |
Why?
|
| Specimen Handling | 1 | 2013 | 33 | 0.110 |
Why?
|
| Birth Weight | 1 | 2014 | 63 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 961 | 0.110 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2013 | 6 | 0.100 |
Why?
|
| Lipocalins | 1 | 2013 | 3 | 0.100 |
Why?
|
| Weight Gain | 1 | 2014 | 75 | 0.100 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2013 | 8 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 465 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 121 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 409 | 0.100 |
Why?
|
| Comorbidity | 1 | 2013 | 258 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 134 | 0.100 |
Why?
|
| Age Factors | 3 | 2010 | 734 | 0.100 |
Why?
|
| Oxidants | 1 | 2012 | 31 | 0.100 |
Why?
|
| Hippocampus | 1 | 2013 | 188 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 26 | 0.100 |
Why?
|
| Dithionitrobenzoic Acid | 1 | 2012 | 3 | 0.100 |
Why?
|
| Extracellular Space | 1 | 2012 | 26 | 0.100 |
Why?
|
| Reference Standards | 1 | 2012 | 57 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 77 | 0.090 |
Why?
|
| Ventricular Myosins | 1 | 2011 | 1 | 0.090 |
Why?
|
| Connexins | 1 | 2011 | 3 | 0.090 |
Why?
|
| Models, Animal | 1 | 2012 | 129 | 0.090 |
Why?
|
| Chemokines | 1 | 2012 | 74 | 0.090 |
Why?
|
| NADPH Oxidase 4 | 1 | 2011 | 8 | 0.090 |
Why?
|
| Escherichia coli Infections | 1 | 2012 | 45 | 0.090 |
Why?
|
| DNA | 2 | 2004 | 374 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 1 | 2011 | 28 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 202 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 79 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2011 | 24 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2015 | 484 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 69 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 61 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 114 | 0.090 |
Why?
|
| Echocardiography | 1 | 2011 | 108 | 0.090 |
Why?
|
| Collagen | 1 | 2012 | 156 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 191 | 0.090 |
Why?
|
| Logistic Models | 1 | 2012 | 407 | 0.090 |
Why?
|
| Phagocytes | 1 | 2010 | 15 | 0.090 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 84 | 0.090 |
Why?
|
| Down Syndrome | 1 | 2010 | 19 | 0.090 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2010 | 28 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2010 | 11 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2010 | 59 | 0.090 |
Why?
|
| Hepatocytes | 2 | 2024 | 80 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 197 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 2 | 2006 | 12 | 0.080 |
Why?
|
| Alanine Transaminase | 2 | 2006 | 27 | 0.080 |
Why?
|
| Thromboxane B2 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2009 | 2 | 0.080 |
Why?
|
| Creatinine | 2 | 2006 | 59 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2010 | 152 | 0.080 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2007 | 2 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 246 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 1054 | 0.070 |
Why?
|
| Alkylation | 1 | 2006 | 18 | 0.070 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 40 | 0.070 |
Why?
|
| Ornithine | 1 | 2006 | 2 | 0.060 |
Why?
|
| Adolescent | 3 | 2019 | 3122 | 0.060 |
Why?
|
| Blotting, Southern | 1 | 2004 | 27 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 43 | 0.060 |
Why?
|
| Introns | 1 | 2004 | 43 | 0.060 |
Why?
|
| Carmustine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 6 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 722 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2004 | 111 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2018 | 433 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 208 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2004 | 21 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 257 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 328 | 0.050 |
Why?
|
| Colon | 1 | 2024 | 121 | 0.050 |
Why?
|
| Base Sequence | 1 | 2004 | 586 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 250 | 0.050 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2002 | 25 | 0.050 |
Why?
|
| Mammary Glands, Human | 1 | 2022 | 19 | 0.050 |
Why?
|
| Fasting | 1 | 2002 | 82 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2022 | 16 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2025 | 352 | 0.050 |
Why?
|
| Bacteria | 1 | 2024 | 281 | 0.050 |
Why?
|
| Sleep | 1 | 2022 | 108 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2022 | 72 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2021 | 19 | 0.050 |
Why?
|
| Mothers | 1 | 2022 | 122 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 285 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 247 | 0.040 |
Why?
|
| Mutation | 1 | 2004 | 847 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2020 | 57 | 0.040 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 2 | 2010 | 6 | 0.040 |
Why?
|
| Levonorgestrel | 1 | 2019 | 6 | 0.040 |
Why?
|
| Desogestrel | 1 | 2019 | 2 | 0.040 |
Why?
|
| Contraception | 1 | 2019 | 22 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 25 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 8 | 0.040 |
Why?
|
| Cervix Uteri | 1 | 2019 | 65 | 0.040 |
Why?
|
| Choriocarcinoma | 1 | 2018 | 6 | 0.040 |
Why?
|
| Mitochondria | 1 | 2002 | 369 | 0.040 |
Why?
|
| Twins | 1 | 2018 | 7 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 224 | 0.040 |
Why?
|
| Diet Records | 1 | 2018 | 11 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2018 | 88 | 0.040 |
Why?
|
| Choline | 1 | 2018 | 20 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2018 | 48 | 0.040 |
Why?
|
| Vitamin A | 1 | 2018 | 26 | 0.040 |
Why?
|
| Placebos | 1 | 2018 | 48 | 0.040 |
Why?
|
| Constipation | 1 | 2018 | 22 | 0.040 |
Why?
|
| Vitamin D | 1 | 2018 | 50 | 0.040 |
Why?
|
| Child Behavior | 1 | 2018 | 28 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 57 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2018 | 95 | 0.030 |
Why?
|
| Corn Oil | 1 | 2017 | 2 | 0.030 |
Why?
|
| Soybean Oil | 1 | 2017 | 3 | 0.030 |
Why?
|
| Ohio | 1 | 2016 | 9 | 0.030 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Auranofin | 1 | 2016 | 5 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2016 | 22 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2017 | 189 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 36 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 385 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 125 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1013 | 0.030 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2016 | 68 | 0.030 |
Why?
|
| Acridine Orange | 1 | 2014 | 1 | 0.030 |
Why?
|
| Ethidium | 1 | 2014 | 6 | 0.030 |
Why?
|
| DNA Fragmentation | 1 | 2014 | 18 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 113 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 473 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2014 | 18 | 0.030 |
Why?
|
| Free Radicals | 1 | 2014 | 39 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 50 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2014 | 72 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 547 | 0.030 |
Why?
|
| Endotoxins | 1 | 2013 | 28 | 0.030 |
Why?
|
| Streptococcus agalactiae | 1 | 2013 | 12 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 2013 | 36 | 0.030 |
Why?
|
| Leukocytes | 1 | 2013 | 71 | 0.030 |
Why?
|
| Species Specificity | 2 | 2004 | 192 | 0.030 |
Why?
|
| United States | 1 | 2018 | 2146 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 692 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 551 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2013 | 226 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 118 | 0.020 |
Why?
|
| Riboflavin Deficiency | 1 | 2010 | 2 | 0.020 |
Why?
|
| Nitrites | 1 | 2010 | 30 | 0.020 |
Why?
|
| Nitrates | 1 | 2010 | 51 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 63 | 0.020 |
Why?
|
| Lung Compliance | 1 | 2010 | 3 | 0.020 |
Why?
|
| Airway Resistance | 1 | 2010 | 4 | 0.020 |
Why?
|
| Peroxidase | 1 | 2010 | 39 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 58 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 36 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 507 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 337 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 403 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 20 | 0.020 |
Why?
|
| Air | 1 | 2008 | 23 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2008 | 18 | 0.020 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2007 | 5 | 0.020 |
Why?
|
| Phenotype | 1 | 2010 | 681 | 0.020 |
Why?
|
| Citrulline | 1 | 2006 | 3 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 40 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 55 | 0.020 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2004 | 7 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2004 | 19 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 35 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 137 | 0.010 |
Why?
|
| Aging | 1 | 2007 | 968 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 634 | 0.010 |
Why?
|